A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
for KRAS P.G12C
Sites in Nashville +6 more locations
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All·Age: 18+
Code: NCT05410145·Phase 1, Phase 2·Recruiting·Listed Jun 2022